Overexpression of Cytoplasmic TcSIR2RP1 and Mitochondrial TcSIR2RP3 Impacts on Trypanosoma cruzi Growth and Cell Invasion (original) (raw)

Characterization of Trypanosoma cruzi sirtuins as possible drug targets for Chagas Disease

Maria Isabel Nogueira Cano

Antimicrobial Agents and Chemotherapy, 2015

View PDFchevron_right

Identification of Inhibitors to Trypanosoma cruzi Sirtuins Based on Compounds Developed to Human Enzymes

Dante Rotili

International Journal of Molecular Sciences, 2020

View PDFchevron_right

Inhibitors of Trypanosoma cruzi Sir2 related protein 1 as potential drugs against Chagas disease

Iain Pemberton

PLoS neglected tropical diseases, 2018

View PDFchevron_right

Inhibition of NAD+-dependent histone deacetylases (sirtuins) causes growth arrest and activates both apoptosis and autophagy in the pathogenic protozoan Trypanosoma cruzi

Lissa Reignault

Parasitology, 2014

View PDFchevron_right

Trypanosoma cruzi Sirtuin 2 as a Relevant Druggable Target: New Inhibitors Developed by Computer-Aided Drug Design

Glaucio Monteiro Ferreira

Pharmaceuticals

View PDFchevron_right

An Atypical Mitochondrial Carrier That Mediates Drug Action in Trypanosoma brucei

Juan Antonio Posadas Macedo

PLOS Pathogens, 2015

View PDFchevron_right

Anti-Trypanosoma cruzi activity of nicotinamide

Elisalva Guimarães

Acta Tropica, 2012

View PDFchevron_right

Investigation of Trypanothione Reductase as a Drug Target in Trypanosoma brucei

Stuart McElroy

ChemMedChem, 2009

View PDFchevron_right

The double-edged sword in pathogenic trypanosomatids: the pivotal role of mitochondria in oxidative stress and bioenergetics

Solange Castro, Rubem Menna-barreto

BioMed research international, 2014

View PDFchevron_right

Computational Studies on Sirtuins from Trypanosoma cruzi: Structures, Conformations and Interactions with Phytochemicals

Giuseppe Randazzo

PLoS Neglected Tropical Diseases, 2014

View PDFchevron_right

Comparative structural, kinetic and inhibitor studies of Trypanosoma brucei trypanothione reductase with T. cruzi

Antonio Ariza

View PDFchevron_right

Characterization of a Trypanosoma cruzi acetyltransferase: cellular location, activity and structure☆

Abhiman Saraswathi

Molecular and Biochemical Parasitology, 2007

View PDFchevron_right

Silent Information Regulator 2 from Trypanosoma cruzi Is a Potential Target to Infection Control

Anabela Cordeiro-da-silva

Chagas Disease - Basic Investigations and Challenges, 2018

View PDFchevron_right

Molecular characterization and interactome analysis of Trypanosoma cruzi Tryparedoxin 1

Diego Arias

Journal of Proteomics, 2011

View PDFchevron_right

KH-TFMDI, a novel sirtuin inhibitor, alters the cytoskeleton and mitochondrial metabolism promoting cell death in Leishmania amazonensis

Wanderley de Souza

Apoptosis : an international journal on programmed cell death, 2017

View PDFchevron_right

In silico investigation of cytochrome bc1 molecular inhibition mechanism against Trypanosoma cruzi

Andrea Danani

View PDFchevron_right

New Therapeutic Targets for Drug Design Against Trypanosoma cruzi, Advances and Perspectives

Gildardo Rivera

Current Medicinal Chemistry, 2009

View PDFchevron_right

Validation of Trypanosoma brucei trypanothione synthetase as drug target

Marcelo Comini

Free radical biology & medicine, 2004

View PDFchevron_right

Mitochondrial Redox Metabolism in Trypanosomatids Is Independent of Tryparedoxin Activity

Ana Tomas

PLoS ONE, 2010

View PDFchevron_right

Molecular characterisation of mitochondrial and cytosolic trypanothione-dependent tryparedoxin peroxidases in Trypanosoma brucei

Alan Prescott

Molecular and Biochemical Parasitology, 2001

View PDFchevron_right

Insights into the redox biology of Trypanosoma cruzi: Trypanothione metabolism and oxidant detoxification

Leopold A N Flohe

Free Radical Biology and Medicine, 2008

View PDFchevron_right

New Insights into the Role of the Trypanosoma cruzi Aldo-Keto Reductase TcAKR

Laura Chiribao

Pathogens

View PDFchevron_right

Valdiation of Trypanosoma brucei trypanothione synthetase as drug target

Heinrich Lünsdorf, Leopold A N Flohe

Free Radical Biology and Medicine, 2004

View PDFchevron_right

Targeting the nucleotide metabolism of Trypanosoma brucei and other trypanosomatids

Anders Hofer

FEMS Microbiology Reviews

View PDFchevron_right

Trypanosoma brucei:Molecular Cloning and Stage-Regulated Expression of a Malate Dehydrogenase Localized to the Mitochondrion

Victoria Carter

Experimental Parasitology, 1998

View PDFchevron_right

From the cell biology to the development of new chemotherapeutic approaches against trypanosomatids: dreams and reality

Wanderley de Souza

Kinetoplastid Biology and Disease, 2002

View PDFchevron_right

Chagasin, the endogenous cysteine-protease inhibitor of Trypanosoma cruzi, modulates parasite differentiation and invasion of mammalian cells

Camila Santos

Journal of Cell Science, 2005

View PDFchevron_right

The TryPIKinome of five human pathogenic trypanosomatids: Trypanosoma brucei, Trypanosoma cruzi, Leishmania major, Leishmania braziliensis and Leishmania infantum – New tools for designing specific inhibitors

Diana Bahia

Biochemical and Biophysical Research Communications, 2009

View PDFchevron_right